Skip to main content

Advertisement

Table 2 Peri- and post transplant clinical data of the study group

From: Short and long-term metabolic outcomes in patients with type 1 and type 2 diabetes receiving a simultaneous pancreas kidney allograft

VariablesT1DM SPK (n = 89)T2 DM SPK (n = 12)T2DM KTA (n = 26)p-value
One-year cumulative combined kidney and pancreas Rejection
 Yes19 (21.3%)7 (58.3%)4 (15.4%)n.s.
 No70 (78.7.%)5 (41.7%)22 (84.6%) 
DGF Pancreas  N.A.n.s.
 Yes4 (4.5%)1 (8.3%)  
 No85 (95.5%)11 (91.7%)  
DGF kidney   0.04
 Yes13 (14.9%)2 (16.7%)11 (42.3%) 
 No74 (85.1%)10 (83.3%)15 (57.7%) 
Infectious Complications   n.s.
 Yes18 (20.2%)4 (33.3%)10 (38.4%) 
 No71 (79.8%)8 (66.7%)16 (61.6%) 
Pancreas Complications
 Graft Thrombosis
  Yes9 (10%)1 (9.1%)N.A.n.s.
  No79 (90%)11 (90.9%)  
 Abscess/local Infection
  Yes6 (6.7%)1 (8.3%)N.A.n.s.
  No83 (93.3%)11 (91.7%)  
 Anastomotic leak
  Yes1 (1.1%)0N.A.n.s.
  No0 (98.9%)0  
 Pancreatitis
  Yes11 (12.2%)2 (18.2%)N.A.n.s.
  No79 (78.2%)10 (81.8%)  
 Bleeding
  Yes8 (9%)2 (16.7%)N.A.n.s.
  No81 (91%)10 (83.3%)  
C-peptide at discharge, mean (SD), ng/ml2.28 (1.8)3.19 (1.79) n.s.
Creatinine at discharge, mean (SD), ummol/l130.5+/−88.1152.1+/−74.7240.3+/−130.1< 0.01